首页 > 最新文献

The Ulster medical journal最新文献

英文 中文
Planetary Health Report Card for Queen's University Belfast - update. 贝尔法斯特女王大学的 "行星健康成绩单"--更新。
Pub Date : 2024-01-01 Epub Date: 2024-01-29
Ryan McFall, Victoria England, Fionan McBride, Hannah McPhee, Mhairi Cowan, Riley Westwood, Sam Scholes
{"title":"Planetary Health Report Card for Queen's University Belfast - update.","authors":"Ryan McFall, Victoria England, Fionan McBride, Hannah McPhee, Mhairi Cowan, Riley Westwood, Sam Scholes","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"92 3","pages":"170-172"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10824132/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139643782","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Verbal Probability Terms for Communicating Clinical Risk - a Systematic Review. 用于传达临床风险的口头概率术语 - 系统回顾。
Pub Date : 2024-01-01 Epub Date: 2024-05-03
M Jawad Hashim

Verbal probability expressions such as 'likely' and 'possible' are commonly used to communicate uncertainty in diagnosis, treatment effectiveness as well as the risk of adverse events. Probability terms that are interpreted consistently can be used to standardize risk communication. A systematic review was conducted. Research studies that evaluated numeric meanings of probability terms were reviewed. Terms with consistent numeric interpretation across studies were selected and were used to construct a Visual Risk Scale. Five probability terms showed reliable interpretation by laypersons and healthcare professionals in empirical studies. 'Very Likely' was interpreted as 90% chance (range 80 to 95%); 'Likely/Probable,' 70% (60 to 80%); 'Possible,' 40% (30 to 60%); 'Unlikely,' 20% (10 to 30%); and 'Very Unlikely' with 10% chance (5% to 15%). The corresponding frequency terms were: Very Frequently, Frequently, Often, Infrequently, and Rarely, respectively. Probability terms should be presented with their corresponding numeric ranges during discussions with patients. Numeric values should be presented as X-in-100 natural frequency statements, even for low values; and not as percentages, X-in-1000, X-in-Y, odds, fractions, 1-in-X, or as number needed to treat (NNT). A Visual Risk Scale was developed for use in clinical shared decision making.

可能 "和 "可能 "等口头概率表达常用于传达诊断、治疗效果以及不良事件风险方面的不确定性。解释一致的概率术语可用于规范风险交流。我们进行了一项系统性回顾。对评估概率术语数字含义的研究进行了回顾。选择了在不同研究中具有一致数字解释的术语,并将其用于构建视觉风险量表。在实证研究中,有五个概率术语在非专业人士和医护人员中显示出可靠的解释。非常有可能 "被解释为90%的几率(范围为80%至95%);"有可能/可能 "为70%(60%至80%);"可能 "为40%(30%至60%);"不可能 "为20%(10%至30%);"非常不可能 "为10%的几率(5%至15%)。相应的频率术语为相应的频率词分别为:非常频繁、频繁、经常、不频繁和罕见。在与患者讨论时,概率术语应与相应的数值范围一起呈现。数字值应以 X-100(X-in-100)自然频率表述,即使数值较低;而不是以百分比、X-1000(X-in-1000)、X-Y(X-in-Y)、几率、分数、1-X(1-in-X)或治疗所需人数(NNT)表述。为临床共同决策开发了视觉风险量表。
{"title":"Verbal Probability Terms for Communicating Clinical Risk - a Systematic Review.","authors":"M Jawad Hashim","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Verbal probability expressions such as 'likely' and 'possible' are commonly used to communicate uncertainty in diagnosis, treatment effectiveness as well as the risk of adverse events. Probability terms that are interpreted consistently can be used to standardize risk communication. A systematic review was conducted. Research studies that evaluated numeric meanings of probability terms were reviewed. Terms with consistent numeric interpretation across studies were selected and were used to construct a Visual Risk Scale. Five probability terms showed reliable interpretation by laypersons and healthcare professionals in empirical studies. 'Very Likely' was interpreted as 90% chance (range 80 to 95%); 'Likely/Probable,' 70% (60 to 80%); 'Possible,' 40% (30 to 60%); 'Unlikely,' 20% (10 to 30%); and 'Very Unlikely' with 10% chance (5% to 15%). The corresponding frequency terms were: Very Frequently, Frequently, Often, Infrequently, and Rarely, respectively. Probability terms should be presented with their corresponding numeric ranges during discussions with patients. Numeric values should be presented as X-in-100 natural frequency statements, even for low values; and not as percentages, X-in-1000, X-in-Y, odds, fractions, 1-in-X, or as number needed to treat (NNT). A Visual Risk Scale was developed for use in clinical shared decision making.</p>","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"93 1","pages":"18-23"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11067312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140873372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLINICAL PHARMACOLOGY 临床药理学
Pub Date : 2023-06-27 DOI: 10.1007/BF03189435
M. Reidenberg
{"title":"CLINICAL PHARMACOLOGY","authors":"M. Reidenberg","doi":"10.1007/BF03189435","DOIUrl":"https://doi.org/10.1007/BF03189435","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"4 1","pages":"102 - 102"},"PeriodicalIF":0.0,"publicationDate":"2023-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"88371849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Six Year Experience of a National Leadership Fellowship in Northern Ireland: Achieve, Develop, Explore Programme for Trainees (ADEPT) 北爱尔兰国家领导奖学金的六年经验:学员实现、发展、探索计划(ADEPT)
Pub Date : 2023-05-01 DOI: 10.1136/leader-2023-FMLM.15
R. Evans, Sophie Davidson, Amy Taylor, M. Macartney, Sarah Small, W. Elbaroni, Therese McCartney, Peter McMurray, Ian Steele
ABSTRACT Introduction The Achieve, Develop, Explore Programme for Trainees (ADEPT) Clinical Leadership Fellowship Programme was established in response to growing recommendations to underpin healthcare reconfiguration in Northern Ireland with a collective leadership strategy. The fellowship combines a leadership development programme with a project carried out within a host organisation. With the fellowship now in its sixth year, a need was identified to assess its impact on the fellows’ leadership skills, career choices, achievements, and views on both the fellowship and how to develop future leaders. Methods Demographic data for all ADEPT fellows was held centrally through Northern Ireland Medical and Dental Training Agency (NIMDTA) and assessed anonymously. A mixed-methods questionnaire was composed using Smart Survey. Likert scale questions were designed to determine the extent to which participants believed ADEPT supported their development of strong and exemplary elements of the nine dimensions of the NHS Healthcare Leadership Model. The questionnaire was distributed electronically to all ADEPT alumni in November 2021 and remained open for 4 weeks. Results There have been 46 ADEPT fellows to date (72% female; all fellows were white). ADEPT fellows were most commonly from Psychiatry (33%), Paediatrics (17%) and Obstetrics and Gynaecology (15%). There were 19 responses from the alumni cohort of 46 (41%). 75% of respondents reported that their project resulted in publication, presentation or award. Leadership skill development was identified as best in “Evaluating Information” and “Engaging the Team”, whereas skills in “Sharing the Vision” and “Developing Capability” saw less improvement. The majority felt that the fellowship had been useful in securing their position as a consultant or general practitioner and 50% went on to pursue senior leadership positions. Conclusion The ADEPT Clinical Leadership Fellowship delivers effective leadership training as measured by the nine domains of the NHS Healthcare Leadership Model. It provides value for host organisations through the projects undertaken and by developing doctors who are more likely to engage in future formal leadership roles. ADEPT alumni saw the value in their leadership experience and felt it should be embedded in standard postgraduate training schemes to reach a wider audience.
摘要介绍实现,发展,探索方案的学员(ADEPT)临床领导奖学金计划是建立在响应日益增长的建议,以支持医疗保健重组在北爱尔兰与集体领导战略。该奖学金将领导力发展课程与在主办机构内开展的项目相结合。今年是该奖学金的第六个年头,我们认为有必要评估其对奖学金获得者的领导技能、职业选择、成就以及对奖学金和如何培养未来领导者的看法的影响。方法通过北爱尔兰医学和牙科培训机构(NIMDTA)集中保存所有ADEPT研究员的人口统计数据,并进行匿名评估。采用Smart Survey进行问卷调查。李克特量表问题的设计是为了确定参与者相信ADEPT支持他们在NHS医疗保健领导模型的九个维度中发展强大和模范元素的程度。该问卷于2021年11月以电子方式分发给所有ADEPT校友,并保持开放4周。结果共纳入46名ADEPT研究员,其中72%为女性;所有的同伴都是白人)。熟练的研究员通常来自精神病学(33%)、儿科(17%)和妇产科(15%)。来自46名校友(41%)的19份回复。75%的受访者表示他们的项目最终出版、展示或获奖。在“评估信息”和“团队参与”方面,领导技能的发展被认为是最好的,而在“分享愿景”和“发展能力”方面,领导技能的提高幅度较小。大多数人认为,奖学金对他们获得顾问或全科医生的职位很有帮助,50%的人继续追求高级领导职位。结论熟练临床领导奖学金提供有效的领导力培训,通过NHS医疗保健领导模型的九个领域来衡量。它通过承担的项目和培养更有可能从事未来正式领导角色的医生,为主办机构提供价值。ADEPT的校友看到了他们的领导经验的价值,并认为应该将其纳入标准的研究生培训计划,以吸引更广泛的受众。
{"title":"A Six Year Experience of a National Leadership Fellowship in Northern Ireland: Achieve, Develop, Explore Programme for Trainees (ADEPT)","authors":"R. Evans, Sophie Davidson, Amy Taylor, M. Macartney, Sarah Small, W. Elbaroni, Therese McCartney, Peter McMurray, Ian Steele","doi":"10.1136/leader-2023-FMLM.15","DOIUrl":"https://doi.org/10.1136/leader-2023-FMLM.15","url":null,"abstract":"ABSTRACT Introduction The Achieve, Develop, Explore Programme for Trainees (ADEPT) Clinical Leadership Fellowship Programme was established in response to growing recommendations to underpin healthcare reconfiguration in Northern Ireland with a collective leadership strategy. The fellowship combines a leadership development programme with a project carried out within a host organisation. With the fellowship now in its sixth year, a need was identified to assess its impact on the fellows’ leadership skills, career choices, achievements, and views on both the fellowship and how to develop future leaders. Methods Demographic data for all ADEPT fellows was held centrally through Northern Ireland Medical and Dental Training Agency (NIMDTA) and assessed anonymously. A mixed-methods questionnaire was composed using Smart Survey. Likert scale questions were designed to determine the extent to which participants believed ADEPT supported their development of strong and exemplary elements of the nine dimensions of the NHS Healthcare Leadership Model. The questionnaire was distributed electronically to all ADEPT alumni in November 2021 and remained open for 4 weeks. Results There have been 46 ADEPT fellows to date (72% female; all fellows were white). ADEPT fellows were most commonly from Psychiatry (33%), Paediatrics (17%) and Obstetrics and Gynaecology (15%). There were 19 responses from the alumni cohort of 46 (41%). 75% of respondents reported that their project resulted in publication, presentation or award. Leadership skill development was identified as best in “Evaluating Information” and “Engaging the Team”, whereas skills in “Sharing the Vision” and “Developing Capability” saw less improvement. The majority felt that the fellowship had been useful in securing their position as a consultant or general practitioner and 50% went on to pursue senior leadership positions. Conclusion The ADEPT Clinical Leadership Fellowship delivers effective leadership training as measured by the nine domains of the NHS Healthcare Leadership Model. It provides value for host organisations through the projects undertaken and by developing doctors who are more likely to engage in future formal leadership roles. ADEPT alumni saw the value in their leadership experience and felt it should be embedded in standard postgraduate training schemes to reach a wider audience.","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"4 1","pages":"93 - 97"},"PeriodicalIF":0.0,"publicationDate":"2023-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76352099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
UNDERSTANDING MEDICINE 了解医学
Pub Date : 2023-02-28 DOI: 10.1007/s10670-023-00665-8
S. Varga
{"title":"UNDERSTANDING MEDICINE","authors":"S. Varga","doi":"10.1007/s10670-023-00665-8","DOIUrl":"https://doi.org/10.1007/s10670-023-00665-8","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"81 1","pages":"81 - 81"},"PeriodicalIF":0.0,"publicationDate":"2023-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78904434","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Curiositas
Pub Date : 2022-08-02 DOI: 10.1163/2352-0272_emho_dum_018149
A. Vage
{"title":"Curiositas","authors":"A. Vage","doi":"10.1163/2352-0272_emho_dum_018149","DOIUrl":"https://doi.org/10.1163/2352-0272_emho_dum_018149","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"67 1","pages":"178 - 179"},"PeriodicalIF":0.0,"publicationDate":"2022-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"76982988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vocation in medicine 医学职业
Pub Date : 2022-05-01 DOI: 10.1016/s0140-6736(48)91501-3
M. Trimble
{"title":"Vocation in medicine","authors":"M. Trimble","doi":"10.1016/s0140-6736(48)91501-3","DOIUrl":"https://doi.org/10.1016/s0140-6736(48)91501-3","url":null,"abstract":"","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"45 1","pages":"65 - 66"},"PeriodicalIF":0.0,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73301469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RESPONSE TIMES FOR ACUTE NON-INVASIVE VENTILATION SET-UPS 急性无创通气装置的反应时间
Pub Date : 2021-11-01 DOI: 10.1136/thorax-2021-btsabstracts.125
A. Watson, H. Barnard, A. Shanmugarajah, P. Antoine-Pitterson, R. Mukherjee
NIV is a lifesaving treatment in chronic obstructive pulmonary disease (COPD). Prompt NIV treatment in hypercapnic COPD exacerbations allows for improved physiological outcomes, reduced intubation rates and shortened hospital stay in (1, 2). Therefore, consensus expert opinion is that prompt application of acute NIV substantially reduces the risk of death and should be started without delay in appropriately selected patients with acute hypercapnic respiratory failure (AHRF).The ‘door-to-mask’ time (hospital arrival to NIV commencement: target ≤120 minutes) has been widely used to measure the quality of acute NIV services as per the 2018
NIV是一种挽救慢性阻塞性肺疾病(COPD)生命的治疗方法。在高碳酸血症性COPD加重期及时应用NIV可改善生理结果,降低插管率并缩短住院时间(1,2)。因此,专家一致认为,及时应用急性NIV可大大降低死亡风险,应在适当选择的急性高碳酸血症性呼吸衰竭(AHRF)患者中立即开始。“从门到口罩”的时间(医院到达NIV开始:目标≤120分钟)已被广泛用于衡量急性NIV服务的质量
{"title":"RESPONSE TIMES FOR ACUTE NON-INVASIVE VENTILATION SET-UPS","authors":"A. Watson, H. Barnard, A. Shanmugarajah, P. Antoine-Pitterson, R. Mukherjee","doi":"10.1136/thorax-2021-btsabstracts.125","DOIUrl":"https://doi.org/10.1136/thorax-2021-btsabstracts.125","url":null,"abstract":"NIV is a lifesaving treatment in chronic obstructive pulmonary disease (COPD). Prompt NIV treatment in hypercapnic COPD exacerbations allows for improved physiological outcomes, reduced intubation rates and shortened hospital stay in (1, 2). Therefore, consensus expert opinion is that prompt application of acute NIV substantially reduces the risk of death and should be started without delay in appropriately selected patients with acute hypercapnic respiratory failure (AHRF).The ‘door-to-mask’ time (hospital arrival to NIV commencement: target ≤120 minutes) has been widely used to measure the quality of acute NIV services as per the 2018","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"1 1","pages":"169 - 170"},"PeriodicalIF":0.0,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83115559","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rhabdomyolysis: Revisited. 横纹肌溶解症:再访。
Pub Date : 2021-05-01 Epub Date: 2021-07-08
Ankur Gupta, Peter Thorson, Krishnam R Penmatsa, Pritam Gupta

Rhabdomyolysis (RML) is a pathological entity characterized by symptoms of myalgia, weakness and dark urine (which is often not present) resulting in respiratory failure and altered mental status. Laboratory testing for myoglobinuria is pathognomonic but so often not present during the time of testing that serum creatine kinase should always be sent when the diagnosis is suspected. Kidney injury from RML progresses through multiform pathways resulting in acute tubular necrosis. Early treatment (ideally<6 hoursfrom onset) is needed with volume expansion of all non-overloaded patients along with avoidance of nephrotoxins. There is insufficient data to recommend any specific fluid. The mortality rate ranges from 10% to up to 50% with severe AKI, so high index of suspicion and screening should be in care plan of seriously ill patients at risk for RML.

横纹肌溶解症(RML)是一种病理实体,其特征是肌痛、虚弱和黑尿(通常不存在)症状,导致呼吸衰竭和精神状态改变。肌红蛋白尿的实验室检测是病理性的,但在检测期间通常不存在,因此当怀疑诊断时,应始终发送血清肌酸激酶。RML引起的肾脏损伤通过多种途径发展,导致急性肾小管坏死。早期治疗(理想情况下
{"title":"Rhabdomyolysis: Revisited.","authors":"Ankur Gupta,&nbsp;Peter Thorson,&nbsp;Krishnam R Penmatsa,&nbsp;Pritam Gupta","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Rhabdomyolysis (RML) is a pathological entity characterized by symptoms of myalgia, weakness and dark urine (which is often not present) resulting in respiratory failure and altered mental status. Laboratory testing for myoglobinuria is pathognomonic but so often not present during the time of testing that serum creatine kinase should always be sent when the diagnosis is suspected. Kidney injury from RML progresses through multiform pathways resulting in acute tubular necrosis. Early treatment (ideally<6 hoursfrom onset) is needed with volume expansion of all non-overloaded patients along with avoidance of nephrotoxins. There is insufficient data to recommend any specific fluid. The mortality rate ranges from 10% to up to 50% with severe AKI, so high index of suspicion and screening should be in care plan of seriously ill patients at risk for RML.</p>","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"90 2","pages":"61-69"},"PeriodicalIF":0.0,"publicationDate":"2021-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a7/73/umj-90-02-61.PMC8278949.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41169298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REPRODUCTIVE ENDOCRINOLOGY 生殖内分泌学
Pub Date : 2020-02-08 DOI: 10.1093/humrep/11.suppl_1.163
M. L. Moore
The prevention and clinical management of RDS are discussed in detail, of particular interest being the details of the use of Swan-Ganz catheters, anticoagulants in the management of intravascular coagulation, post end-expiratory pressure and intravenous nutrition. Not everyone will agree with the opinions expressed but their rational presentation supported by an excellent bibliography are certainly stimulating.
详细讨论了RDS的预防和临床管理,特别感兴趣的是Swan-Ganz导管的使用细节,血管内凝血管理中的抗凝剂,呼气末压和静脉营养。不是每个人都会同意所表达的观点,但他们的理性表达支持一个优秀的参考书目肯定是刺激。
{"title":"REPRODUCTIVE ENDOCRINOLOGY","authors":"M. L. Moore","doi":"10.1093/humrep/11.suppl_1.163","DOIUrl":"https://doi.org/10.1093/humrep/11.suppl_1.163","url":null,"abstract":"The prevention and clinical management of RDS are discussed in detail, of particular interest being the details of the use of Swan-Ganz catheters, anticoagulants in the management of intravascular coagulation, post end-expiratory pressure and intravenous nutrition. Not everyone will agree with the opinions expressed but their rational presentation supported by an excellent bibliography are certainly stimulating.","PeriodicalId":94250,"journal":{"name":"The Ulster medical journal","volume":"47 1","pages":"99 - 99"},"PeriodicalIF":0.0,"publicationDate":"2020-02-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74264485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
The Ulster medical journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1